• Revenue of $4.43 million, up 1.6% year-on-year
• Net loss reduced by $620,000 to $1.74 million
• Expansion of B2B and wholesale ingredients channel

The Calmer Co. International Limited is a vertically integrated producer of kava-based products operating across retail e-commerce and B2B channels in Australia, the United States, and the Pacific. The Group's portfolio includes the Fiji Kava®, Taki Mai®, and Danodane® brands, spanning traditional kava powders, extracts, ready-to-drink formats, and complementary medicinal products. The first half of FY26 represented a period of operational consolidation and margin discipline, following significant channel expansion in FY25. While revenue growth moderated on a half-year basis, the Group delivered a material improvement in earnings quality, supported by disciplined cost management, improved channel mix, and targeted investment in higher-margin B2B ingredients. For the six months ended 31 December 2025, revenue totaled $4.43 million, broadly stable year-on-year. Importantly, the Group reduced its net loss by approximately $620,000 compared to the prior corresponding period, reflecting a 26% improvement in loss performance, despite continued investment in growth initiatives. Strategic focus during the period included the expansion of the B2B and wholesale ingredients channel, underpinned by increased research and development investment in next-generation CO2 extract formats. This channel is intended to support improved margins and operating leverage as volumes scale, while the Group continues to grow its established retail and e-commerce platforms.

The Group expects to deliver approximately $1,581,884 in minimum contracted revenue over 24 months from a new Master Supply Agreement with a U.S.-based functional beverage company for the supply of premium CO2-extracted kava ingredients.

The Board remains focused on progressing the Group toward sustainable cash-flow breakeven, supported by disciplined cost management, improving channel mix, and continued growth in higher-margin revenue streams. Key areas of focus include the expansion of B2B and wholesale ingredient revenues, continued growth of U.S. operations, operational leverage from manufacturing investments, working capital discipline and inventory optimisation, and continued investment in product development and innovation.